Rivia unifies clinical trial data and integrates AI agents into review workflows to reduce trial costs. The Zurich startup has raised USD 15 million in a Series A led by Earlybird to grow its team and expand into the United States.
- Announced on
- Round
- Series A
- Amount
- USD 15 M
- Location
- Zurich
- Sector
- Health & medtech, Software & SaaS
Investors
- Earlybird lead
- Defiant
- Speedinvest
- Amino Collective
- Nina Capital
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic